Vaxxinity celebrates trial success in early Parkinson’s therapy

cafead

Administrator
Staff member
  • cafead   Jun 23, 2023 at 09:52: AM
via Vaxxinity has announced that the Phase I clinical trial for its Parkinson’s vaccine (UB-312) met the primary objectives, achieving antibody response in early Parkinson’s disease (PD).

article source